PharmaMar, Chugai deal

PharmaMar granted Chugai rights to promote Aplidin plitidepsin to treat multiple myeloma (MM) in the U.K., France, Germany, Belgium, the Netherlands, Luxemburg, Ireland and Austria. PharmaMar receive...